178 results on '"Numata, Ayumi"'
Search Results
2. Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation
3. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort
4. Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study
5. Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation
6. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation
7. Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy
8. R-CHOP therapy alone for limited-stage follicular lymphoma
9. Driver Rehabilitation for Patients with Acquired Brain Injury in Koriyama, Fukushima District
10. Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantation
11. The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation
12. Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy
13. Favorable prognosis in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia patients following hematopoietic stem cell transplantation
14. Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy
15. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
16. Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in Japan
17. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation
18. R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma
19. Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
20. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
21. Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study
22. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma
23. Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation
24. Predictive values of early suppression of tumorigenicity 2 for acute GVHD and transplant-related complications after allogeneic stem cell transplantation: prospective observational study
25. Anemia associated with worse outcome in diffuse large B-cell lymphoma patients: a single-center retrospective study
26. The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis
27. The efficacy of a simple surveillance and ordering system for hepatitis virus B reactivation
28. Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation
29. Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia
30. Validation of the Composite End Point of Graft-Versus-Host Disease-Free, Relapse-Free Survival
31. Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient
32. Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis
33. Amrubicin therapy for platinum-refractory extrapulmonary neuroendocrine carcinoma: Retrospective single-center analysis
34. Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation
35. Clinical significance of serum ferritin compared to liver iron content, measured using magnetic resonance imaging, after allogeneic hematopoietic cell transplantation
36. Beta-2 Microglobulin As a Strong Prognostic Factor in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
37. Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.
38. Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.
39. Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantation
40. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone
41. SY-2-5 - The efficacy of a simple surveillance and ordering system for hepatitis virus B reactivation
42. Hyper-Recovery Of Platelet After Induction Therapy Is a Significant Predictor For Relapse In Acute Myeloid Leukemia
43. Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin Lymphoma
44. Retrospective Study of Standard R-CHOP Therapy in Localized DLBCL
45. Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum
46. Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant
47. Retrospective Study of the Utility of FLIPI/FLIPI-2 for Follicular Lymphoma Patients Treated with R-CHOP
48. Successful hemochromatosis following allogeneic stem cell transplantation for acute lymphoblastic leukemia
49. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
50. Multicenter Validation of the Scoring System of Pre-Transplant Serum Ferritin and Disease Risk in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.